USANA HEALTH SCIENCES INCUSNA

Neutral

ASignal's systematic analysis rates USNA as Neutral.

Reflects the latest available analysis · analyzed Oct 11, 2026

The case on USNA

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong gross margin of 77.45% indicating pricing power
  • Zero debt and $168.56M in cash suggesting robust financial health
  • Free cash flow of $49.13M supports operational efficiency
  • Low valuation metrics: EV/Revenue 0.16x, P/B 0.51x, P/S 0.30x
VS
Bear case
  • Negative net margin of -2.43% and negative ROE of -5.06%
  • Declining revenue growth (YoY -5.3%)
  • Lack of earnings growth data and high forward PEG ratio of 0.69x
  • Low news coverage with only one source (Yahoo)
  • No Reddit mentions indicating minimal retail interest
Subscriber-only

See the full verdict on USNA

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes USNA

Most investors never get a second opinion, let alone several. ASignal runs USNA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

USANA HEALTH SCIENCES INC (USNA) Stock Analysis - ASignal rates it Neutral